139 related articles for article (PubMed ID: 29421568)
1. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo.
Li N; Xin WY; Yao BR; Wang CH; Cong W; Zhao F; Li HJ; Hou Y; Meng QG; Hou GG
Eur J Med Chem; 2018 Mar; 147():21-33. PubMed ID: 29421568
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation.
Zhang L; Chen Q; Hou G; Zhao W; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):264-271. PubMed ID: 30734613
[TBL] [Abstract][Full Text] [Related]
3. Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.
Yao BR; Sun Y; Chen SL; Suo HD; Zhang YL; Wei H; Wang CH; Zhao F; Cong W; Xin WY; Hou GG
Eur J Med Chem; 2019 Apr; 167():187-199. PubMed ID: 30771605
[TBL] [Abstract][Full Text] [Related]
4. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.
Cong W; Sun Y; Sun YF; Yan WB; Zhang YL; Gao ZF; Wang CH; Hou GG; Zhang JJ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1622-1631. PubMed ID: 34284695
[TBL] [Abstract][Full Text] [Related]
5. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
Li N; Xin WY; Yao BR; Cong W; Wang CH; Hou GG
Eur J Med Chem; 2018 Jul; 155():531-544. PubMed ID: 29909338
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antitumor activity evaluation of some new N-aroyl-α,β-unsaturated piperidones with fluorescence.
Sun J; Wang S; Li H; Jiang W; Hou G; Zhao F; Cong W
J Enzyme Inhib Med Chem; 2016; 31(3):495-502. PubMed ID: 26382011
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds.
Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR
Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and bioevaluation of novel N-substituted-3,5-bis(arylidene)-4-piperidone derivatives as cytotoxic and antitumor agents with fluorescent properties.
Sun J; Zhang S; Yu C; Hou G; Zhang X; Li K; Zhao F
Chem Biol Drug Des; 2014 Apr; 83(4):392-400. PubMed ID: 24148151
[TBL] [Abstract][Full Text] [Related]
9. Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.
Das S; Das U; Michel D; Gorecki DK; Dimmock JR
Eur J Med Chem; 2013 Jun; 64():321-8. PubMed ID: 23644215
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel NF-кB inhibitor based on scaffold hopping: 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine.
Sun Y; Gao ZF; Yan WB; Yao BR; Xin WY; Wang CH; Meng QG; Hou GG
Eur J Med Chem; 2020 Jul; 198():112366. PubMed ID: 32371335
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity.
Kálai T; Kuppusamy ML; Balog M; Selvendiran K; Rivera BK; Kuppusamy P; Hideg K
J Med Chem; 2011 Aug; 54(15):5414-21. PubMed ID: 21702507
[TBL] [Abstract][Full Text] [Related]
12. Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer Activity.
Schmitt F; Subramaniam D; Anant S; Padhye S; Begemann G; Schobert R; Biersack B
ChemMedChem; 2018 Jun; 13(11):1115-1123. PubMed ID: 29570947
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
Buduma K; Chinde S; Dommati AK; Sharma P; Shukla A; Srinivas KVNS; Arigari NK; Khan F; Tiwari AK; Grover P; Jonnala KK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1633-1638. PubMed ID: 26873414
[TBL] [Abstract][Full Text] [Related]
14. Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones.
Hossain M; Das U; Umemura N; Sakagami H; Balzarini J; De Clercq E; Kawase M; Dimmock JR
Bioorg Med Chem; 2016 May; 24(10):2206-14. PubMed ID: 27073056
[TBL] [Abstract][Full Text] [Related]
15. 3,5-Bis(3-alkylaminomethyl-4-hydroxybenzylidene)-4-piperidones: A Novel Class of Potent Tumor-Selective Cytotoxins.
Karki SS; Das U; Umemura N; Sakagami H; Iwamoto S; Kawase M; Balzarini J; De Clercq E; Dimmock SG; Dimmock JR
J Med Chem; 2016 Jan; 59(2):763-9. PubMed ID: 26727215
[TBL] [Abstract][Full Text] [Related]
16. Design, cytotoxic and fluorescent properties of novel N-phosphorylalkyl substituted E,E-3,5-bis(arylidene)piperid-4-ones.
Makarov MV; Rybalkina EY; Röschenthaler GV; Short KW; Timofeeva TV; Odinets IL
Eur J Med Chem; 2009 May; 44(5):2135-44. PubMed ID: 19046794
[TBL] [Abstract][Full Text] [Related]
17. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
[TBL] [Abstract][Full Text] [Related]
18. Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-кB activation.
Su CM; Hou GG; Wang CH; Zhang HQ; Yang C; Liu M; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1287-1297. PubMed ID: 31288582
[TBL] [Abstract][Full Text] [Related]
19. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
20. 1-(2-((Z)-6-(2-(Trifluoromethyl)phenyl)hexa-3-en-1,5-diynyl)phenyl)piperidin-2-one as a new potent apoptosis agent.
Tu YS; Duh TH; Tseng CY; Lin YT; Lo YH; Hu YL; Chen CH; Chien CM; Yang SH; Lin SR; Yang SC; Wu MJ
Bioorg Med Chem; 2009 Nov; 17(21):7412-7. PubMed ID: 19818634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
